|
1
|
Tamura R: Current understanding of
neurofibromatosis type 1, 2, and schwannomatosis. Int J Mol Sci.
22(5850)2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Evans DG, Howard E, Giblin C, Clancy T,
Spencer H, Huson SM and Lalloo F: Birth incidence and prevalence of
tumor-prone syndromes: Estimates from a UK family genetic register
service. Am J Med Genet A. 152A:327–332. 2010.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ferner RE and Gutmann DH:
Neurofibromatosis type 1 (NF1): Diagnosis and management. Handb
Clin Neurol. 115:939–955. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Huson SM, Compston DA, Clark P and Harper
PS: A genetic study of von recklinghausen neurofibromatosis in
south east Wales. I. Prevalence, fitness, mutation rate, and effect
of parental transmission on severity. J Med Genet. 26:704–711.
1989.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Korf BR: Plexiform neurofibromas. Am J Med
Genet. 89:31–37. 1999.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bayram T, Bayram D and Tireli H:
Neurofibromatosis type 1-related multiple plexiform neurofibromas:
A case report. Turk J Neurol. 26:42–46. 2020.
|
|
7
|
Loughran PA, Ross MA and St Croix CM:
Immunohistochemistry. Curr Protoc. 2(e549)2022.PubMed/NCBI View
Article : Google Scholar
|
|
8
|
Jett K and Friedman JM: Clinical and
genetic aspects of neurofibromatosis 1. Genet Med. 12:1–11.
2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ehara Y, Koga M, Imafuku S, Yamamoto O and
Yoshida Y: Distribution of diffuse plexiform neurofibroma on the
body surface in patients with neurofibromatosis 1. J Dermatol.
47:190–192. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Uusitalo E, Rantanen M, Kallionpää RA,
Pöyhönen M, Leppävirta J, Ylä-Outinen H, Riccardi VM, Pukkala E,
Pitkäniemi J, Peltonen S and Peltonen J: Distinctive cancer
associations in patients with neurofibromatosis type 1. J Clin
Oncol. 34:1978–1986. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Cieza Rivera AM, Lobato Fuertes C,
Fernández-Villa T, Martín Sánchez V and Atallah I: Impact of
neurofibromatosis type 1 on quality of life using the skindex-29
questionnaire quality of life in NF1. Orphanet J Rare Dis.
19(85)2024.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Prause M, Schulz HJ and Wagler D:
Rechnergestützte führung von fermentationsprozessen, teil 2. Acta
Biotechnologica. 4:143–151. 1984.
|
|
13
|
Lin J and Martel W: Cross-sectional
imaging of peripheral nerve sheath tumors: Characteristic signs on
CT, MR imaging, and sonography. AJR Am J Roentgenol. 176:75–82.
2001.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Legius E, Messiaen L, Wolkenstein P,
Pancza P, Avery RA, Berman Y, Blakeley J, Babovic-Vuksanovic D,
Cunha KS, Ferner R, et al: Revised diagnostic criteria for
neurofibromatosis type 1 and legius syndrome: An international
consensus recommendation. Genet Med. 23:1506–1513. 2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Jett K and Friedman JM: Clinical and
genetic aspects of neurofibromatosis 1. Genet Med. 12:1–11.
2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Napolitano F, Dell'Aquila M, Terracciano
C, Franzese G, Gentile MT, Piluso G, Santoro C, Colavito D, Patanè
A, De Blasiis P, et al: Genotype-phenotype correlations in
neurofibromatosis type 1: Identification of novel and recurrent
NF1 gene variants and correlations with neurocognitive
phenotype. Genes (Basel). 13(1130)2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Fisher MJ, Blakeley JO, Weiss BD, Dombi E,
Ahlawat S, Akshintala S, Belzberg AJ, Bornhorst M, Bredella MA, Cai
W, et al: Management of neurofibromatosis type 1-associated
plexiform neurofibromas. Neuro Oncol. 24:1827–1844. 2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Vaassen P, Dürr N, Röhrig A, Willing R and
Rosenbaum T: Trametinib induces neurofibroma shrinkage and enables
surgery. Neuropediatrics. 50:300–303. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Lalor L, Davies OMT, Basel D and Siegel
DH: Café au lait spots: When and how to pursue their genetic
origins. Clin Dermatol. 38:421–431. 2020.PubMed/NCBI View Article : Google Scholar
|
